Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Comparison of Optimal Antipsychotic Treatments for Adults With Schizophrenia
This study is ongoing, but not recruiting participants.
Study NCT00802100 Information provided by National Institute of Mental Health (NIMH)
First Received: December 3, 2008 Last Updated: June 16, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Schizophrenia
More general conditions related to this trial
Mental Disorders
Schizophrenia and Disorders with Psychotic Features
Interventions listed in this trial
Olanzapine
Perphenazine
Aripiprazole
Behavioral Treatment
Metformin
Simvastatin
Benztropine
Additional drug interventions recognized in this trial
Antipsychotic Agents
More general drug interventions related to this trial
Anti-Dyskinesia Agents
Anticholesteremic Agents
Antiemetics
Antilipemic Agents
Antimetabolites
Antiparkinson Agents
Autonomic Agents
Central Nervous System Agents
Central Nervous System Depressants
Cholinergic Agents
Cholinergic Antagonists
Dopamine Agents
Dopamine Antagonists
Dopamine Uptake Inhibitors
Enzyme Inhibitors
Gastrointestinal Agents
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Molecular Mechanisms of Pharmacological Action
Muscarinic Antagonists
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Parasympatholytics
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Serotonin Agents
Serotonin Uptake Inhibitors
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
National Institute of Mental Health (NIMH)
Back to top of Main Content